PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Shortening guide RNA markedly improves specificity of CRISPR-Cas nucleases

2014-01-27
(Press-News.org) Contact information: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Shortening guide RNA markedly improves specificity of CRISPR-Cas nucleases A simple adjustment to a powerful gene-editing tool may be able to improve its specificity. In a report receiving advance online publication in Nature Biotechnology, Massachusetts General Hospital (MGH) investigators describe how adjusting the length of the the guide RNA (gRNA) component of the synthetic enzymes called CRISPR-Cas RNA-guided nucleases (RGNs) can substantially reduce the occurrence of DNA mutations at sites other than the intended target, a limitation the team had previously described just last year.

"Simply by shortening the length of the gRNA targeting region, we saw reductions in the frequencies of unwanted mutations at all of the previously known off-target sites we examined," says J. Keith Joung, MD, PhD, associate chief for Research in the MGH Department of Pathology and senior author of the report. "Some sites showed decreases in mutation frequency of 5,000-fold or more, compared with full length gRNAs, and importantly these truncated gRNAs - which we call tru-gRNAs - are just as efficient as full-length gRNAs at reaching their intended target DNA segments."

CRISPR-Cas RGNs combine a gene-cutting enzyme called Cas9 with a short RNA segment and are used to induce breaks in a complementary DNA segment in order to introduce genetic changes. Last year Joung's team reported finding that, in human cells, CRISPR-Cas RGNs could also cause mutations in DNA sequences with differences of up to five nucleotides from the target, which could seriously limit the proteins' clinical usefulness. The team followed up those findings by investigating a hypothesis that could seem counterintuitive, that shortening the gRNA segment might reduce off-target mutations.

"Some of our experiments from last year suggested that one could mismatch a few nucleotides at one end of the gRNA complementarity region without affecting the targeting activity," Joung explains. "That led us to wonder whether removing these nucleotides could make the system more sensitive to mismatches in the remaining sequence."

Based on a natural system a species of bacteria uses against other pathogens, the CRISPR-Cas RGNs most widely used by researchers includes a 20-nucleotide targeting region within the gRNA. To test their theory, the MGH team constructed RGNs with progressively shorter gRNAs and found that, while gRNAs with targeting segments of 17 or 18 nucleotides were as or more efficient than full-length gRNAs in reaching their targets, those with 15- or 16-nucleotide targeting segments had reduced or no targeting activity. Subsequent experiments found that 17-nucleotide truncated RGNs efficiently induced the desired mutations in human cells with greatly reduced or undetectable off-target effects, even at sites with only one or two mismatches.

"While we don't fully understand the mechanism by which tru-gRNAs reduce off-target effects, our hypothesis is that the original system might have more energy than it needs, enabling it to cleave even imperfectly matched sites," says Joung, who is an associate professor of Pathology at Harvard Medical School. "By shortening the gRNA, we may reduce the energy to a level just sufficient for on-target activity, making the nuclease less able to cleave off-target sites. But more work is needed to define exactly why tru-gRNAs have reduced off-target effects."

### Joung's team has incorporated the capability to find tru-gRNA target sites into ZiFiT Targeter, a freely available software package designed to identify potential target sites for several DNA-editing technologies. ZiFiT is available at http://zifit.partners.org.

Co-lead authors of the Nature Biotechnology report are Yanfang Fu, PhD, and Jeffry Sander, PhD, of the MGH Molecular Pathology Unit. Additional co-authors are Deepak Reyon, PhD, and Vincent Cascio, also of MGH Molecular Pathology. The study was supported by National Institutes of Health Director's Pioneer Award DP1 GM105378, NIH grants R01 GM088040 and P50 HG005550, and the Jim and Ann Orr MGH Research Scholar Award.

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $775 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine.


ELSE PRESS RELEASES FROM THIS DATE:

How does the brain create sequences?

2014-01-27
When you learn how to play the piano, first you have to learn notes, scales and chords and only then will you be able to play a piece of music. The same ...

Long-lived breast stem cells could retain cancer legacy

2014-01-27
Researchers from Melbourne's Walter and Eliza Hall Institute have discovered that breast stem cells and their 'daughters' have a much longer lifespan than previously thought, and are active in puberty ...

Music therapy's positive effects on young cancer patients' coping skills, social integration

2014-01-27
A new study has found that adolescents and young adults undergoing cancer treatment gain coping skills and resilience-related outcomes when they participate in a therapeutic music ...

Quality improvement initiative improves asthma outcomes in teens

2014-01-27
Researchers at Cincinnati Children's Hospital Medical Center have successfully carried out what is believed to be the first initiative conducted exclusively among teenagers to show ...

After the gunshot: Hospitalizations for firearm injuries prevalent among children

2014-01-27
About 20 children per day in the United States are injured by firearms seriously enough to require hospitalization, and more than 6% of these children die from their injuries, according ...

Researchers motivate diabetics to adopt healthy lifestyle

2014-01-27
By means of so-called health coaching, researchers at the University of Copenhagen have helped a large group of diabetics to markedly improve their oral health. The patients assume responsibility for their ...

Highly reliable brain-imaging protocol identifies delays in premature infants

2014-01-25
Infants born prematurely are at elevated risk for cognitive, motor, and behavioral deficits — the severity of which was, until recently, almost impossible to ...

Study backs giving flu vaccine to working-age adults with diabetes

2014-01-25
All people with diabetes should receive influenza vaccination, according to guidelines in most high-income countries, but there has been little evidence to back this policy. However, a new study ...

Space-raised flies show weakened immunity to fungus

2014-01-25
Venturing into space might be a bold adventure, but it may not be good for your immune system. Now a study by researchers at the University of California, Davis and published Jan. 24 in the journal PLOS ...

Academics discover variation in circadian clock protein in fruit flies

2014-01-25
The circadian clock is a molecular network that generates daily rhythms, and is present ...

LAST 30 PRESS RELEASES:

QUT scientists create material to turn waste heat into clean power

Major new report sets out how to tackle the ‘profound and lasting impact’ of COVID-19 on cardiovascular health

Cosmic crime scene: White dwarf found devouring Pluto-like icy world

Major report tackles Covid’s cardiovascular crisis head-on

A third of licensed GPs in England not working in NHS general practice

ChatGPT “thought on the fly” when put through Ancient Greek maths puzzle

Engineers uncover why tiny particles form clusters in turbulent air

GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients

Psoriasis linked to increased risk of vision-threatening eye disease, study finds

Reprogramming obesity: New drug from Italian biotech aims to treat the underlying causes of obesity

Type 2 diabetes may accelerate development of multiple chronic diseases, particularly in the early stages, UK Biobank study suggests

Resistance training may improve nerve health, slow aging process, study shows

Common and inexpensive medicine halves the risk of recurrence in patients with colorectal cancer

SwRI-built instruments to monitor, provide advanced warning of space weather events

Breakthrough advances sodium-based battery design

New targeted radiation therapy shows near-complete response in rare sarcoma patients

Does physical frailty contribute to dementia?

Soccer headers and brain health: Study finds changes within folds of the brain

Decoding plants’ language of light

UNC Greensboro study finds ticks carrying Lyme disease moving into western NC

New implant restores blood pressure balance after spinal cord injury

New York City's medical specialist advantage may be an illusion, new NYU Tandon research shows

Could a local anesthetic that doesn’t impair motor function be within reach?

1 in 8 Italian cetacean strandings show evidence of fishery interactions, with bottlenose and striped dolphins most commonly affected, according to analysis across four decades of data and more than 5

In the wild, chimpanzees likely ingest the equivalent of several alcoholic drinks every day

Warming of 2°C intensifies Arctic carbon sink but weakens Alpine sink, study finds

Bronze and Iron Age cultures in the Middle East were committed to wine production

Indian adolescents are mostly starting their periods at an earlier age than 25 years ago

Temporary medical centers in Gaza known as "Medical Points" (MPs) treat an average of 117 people daily with only about 7 staff per MP

Rates of alcohol-induced deaths among the general population nearly doubled from 1999 to 2024

[Press-News.org] Shortening guide RNA markedly improves specificity of CRISPR-Cas nucleases